Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.
- DOI
- 10.1007/s40257-025-00985-1
- Published
- 2026 Jan
- Container
- American journal of clinical dermatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40257-025-00985-1,
title = {Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.},
author = {Mayo T and Silverberg JI and Armstrong A and Guttman-Yassky E and Blauvelt A and Esdaile B and Kabashima K and Gooderham M and Kircik L and Schneider S and Bennike N and von Eyben R and Martel BC and Røpke MA and Katoh N and Alexis AF},
year = {2026},
journal = {American journal of clinical dermatology},
doi = {10.1007/s40257-025-00985-1},
url = {https://doi.org/10.1007/s40257-025-00985-1}
}RIS
TY - JOUR TI - Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials. AU - Mayo T AU - Silverberg JI AU - Armstrong A AU - Guttman-Yassky E AU - Blauvelt A AU - Esdaile B AU - Kabashima K AU - Gooderham M AU - Kircik L AU - Schneider S AU - Bennike N AU - von Eyben R AU - Martel BC AU - Røpke MA AU - Katoh N AU - Alexis AF PY - 2026 JO - American journal of clinical dermatology DO - 10.1007/s40257-025-00985-1 UR - https://doi.org/10.1007/s40257-025-00985-1 ER -
APA
T, M., JI, S., A, A., E, G., A, B., B, E., K, K., M, G., L, K., S, S., N, B., R, V. E., BC, M., MA, R., N, K., & AF, A. (2026). Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.. American journal of clinical dermatology. https://doi.org/10.1007/s40257-025-00985-1
Source records
- pubmed · retrieved 2026-09-27T00:19:02.405Z